CRBP insider trading
NasdaqCM HealthcareCorbus Pharmaceuticals Holdings, Inc.: insider trade history from SEC Form 4 filings.
About Corbus Pharmaceuticals Holdings, Inc.
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, develops products to defeat serious illness. It develops CRB-701, an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E (MMAE), which is in Phase I clinical trial; CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGFß expressed on cancer cells for the treatment of solid tumors; CRB-913, a highly peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. It has a licensing agreement with Jenrin Discovery, LLC to develop and commercialize the licensed products, including the Jenrin library of approximately 600 compounds, and multiple issued and pending patent filings. The company was incorporated in 2009 and is based in Norwood, Massachusetts.
Company website: www.corbuspharma.com
CRBP insider activity at a glance
FilingIQ tracks 266 insider transactions for CRBP in filings since Jun 9, 2015. The most recent transaction is dated Sep 14, 2026.
Across the full history, 154 open-market purchases
and 39 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on CRBP insider trades is 55.1/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest CRBP Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for CRBP?
- FilingIQ tracks 266 Form 4 insider transactions for CRBP (Corbus Pharmaceuticals Holdings, Inc.), covering filings from Jun 9, 2015 onwards. 5 of those are dated within the last 90 days.
- Are CRBP insiders net buyers or net sellers?
- Across the full Form 4 history for CRBP, 154 transactions (58%) were open-market purchases and 39 (15%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does CRBP insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
- What sector is CRBP in?
- Corbus Pharmaceuticals Holdings, Inc. (CRBP) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $136.17M.
Methodology & sources
Every CRBP insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.